$36.4 Billion is the total value of VIKING GLOBAL INVESTORS LP's 96 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LIFE | Exit | ATYR PHARMA INC | $0 | – | -587,444 | -100.0% | -0.01% | – |
VBIV | Exit | VBI VACCINES INC | $0 | – | -8,798,971 | -100.0% | -0.09% | – |
LI | Exit | LI AUTO INCsponsored ads | $0 | – | -1,530,611 | -100.0% | -0.10% | – |
NKLA | Exit | NIKOLA CORP | $0 | – | -1,804,176 | -100.0% | -0.13% | – |
FWONK | Exit | LIBERTY MEDIA CORP DEL | $0 | – | -1,427,000 | -100.0% | -0.19% | – |
ALL | Exit | ALLSTATE CORP | $0 | – | -822,509 | -100.0% | -0.28% | – |
ANTM | Exit | ANTHEM INC | $0 | – | -522,405 | -100.0% | -0.51% | – |
CDAY | Exit | CERIDIAN HCM HLDG INC | $0 | – | -2,036,991 | -100.0% | -0.61% | – |
TEAM | Exit | ATLASSIAN CORP PLCcl a | $0 | – | -946,257 | -100.0% | -0.62% | – |
BILL | Exit | BILL COM HLDGS INC | $0 | – | -2,027,963 | -100.0% | -0.74% | – |
EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -2,996,604 | -100.0% | -1.10% | – |
ADI | Exit | ANALOG DEVICES INC | $0 | – | -2,928,432 | -100.0% | -1.24% | – |
RTX | Exit | RAYTHEON TECHNOLOGIES CORP | $0 | – | -6,147,033 | -100.0% | -1.28% | – |
CME | Exit | CME GROUP INC | $0 | – | -2,316,366 | -100.0% | -1.40% | – |
CMCSA | Exit | COMCAST CORP NEWcl a | $0 | – | -10,045,065 | -100.0% | -1.68% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC | 36 | Q3 2023 | 7.0% |
AMAZON COM INC | 34 | Q3 2023 | 10.6% |
META PLATFORMS INC | 34 | Q3 2023 | 10.4% |
MICROSOFT CORP | 30 | Q3 2023 | 9.1% |
THERMO FISHER SCIENTIFIC INC | 29 | Q3 2023 | 5.4% |
NETFLIX INC | 26 | Q2 2023 | 6.0% |
MASTERCARD INCORPORATED | 25 | Q3 2023 | 3.9% |
ELEVANCE HEALTH INC | 24 | Q2 2023 | 10.2% |
ALPHABET INC | 22 | Q2 2021 | 9.3% |
UNITEDHEALTH GROUP INC | 22 | Q3 2023 | 5.3% |
View VIKING GLOBAL INVESTORS LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Celldex Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Coupa Software IncSold out | February 14, 2023 | 0 | 0.0% |
FIGS, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Guardant Health, Inc. | February 14, 2023 | 4,107,644 | 4.0% |
Orion Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
PROCEPT BioRobotics CorpSold out | February 14, 2023 | 0 | 0.0% |
Frazier Lifesciences Acquisition CorpSold out | November 25, 2022 | 0 | 0.0% |
Cazoo Group Ltd | November 10, 2022 | 60,000,000 | 7.3% |
AbCellera Biologics Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Athira Pharma, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
3 | 2024-03-20 |
SC 13G/A | 2024-03-20 |
4 | 2024-03-07 |
4 | 2024-03-07 |
4 | 2024-03-01 |
4 | 2024-03-01 |
SC 13G/A | 2024-03-01 |
4 | 2024-02-28 |
4 | 2024-02-28 |
View VIKING GLOBAL INVESTORS LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.